Mangoceuticals, Inc. (MGRX)

Every figure this model derived for MGRX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2023-12-31
cash 228,688 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 245,687 AssetsCurrent 2026-06-30
current liabilities 1,398,063 LiabilitiesCurrent 2026-06-30
equity 12,525,944 StockholdersEquity 2026-06-30
interest expense 103,513 InterestExpenseNonoperating 2025-12-31
ocf -3,890,874 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 315,227 Revenues 2026-06-30
sbc 2,168,853 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up MGRX on one particular measure came for.

RatioValue
current ratio0.18
current ratio reported0.18
fcf margin-1234.31
growth cv1.43
interest cover-116.6
revenue growth-38.91
revenue growth per share-38.91
roic-77.26
rule of 40-3867.91
sbc pct revenue688.03

What to be careful about

What this model itself distrusts about MGRX's figures. Written by the derivation as it ran, not added afterwards.